Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Infections in patients with multiple sclerosis: A national cohort study in Sweden
Anna Castelo‐Branco, Flaminia Chiesa, Simona Conte, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 45, pp. 102420-102420
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Potentially preventable hospitalizations and use of preventive services among people with multiple sclerosis: Large cohort study, USA
Anam Khan, Paul Lin, Neil Kamdar, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 68, pp. 104105-104105
Open Access | Times Cited: 5
Candida tropicalis Systemic Infection Redirects Leukocyte Infiltration to the Kidneys Attenuating Encephalomyelitis
Natália Munhoz-Alves, Luiza Ayumi Nishiyama Mimura, Rosa Marlene Viero, et al.
Journal of Fungi (2021) Vol. 7, Iss. 9, pp. 757-757
Open Access | Times Cited: 6
Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians
Klara Dyczkowska, Alicja Kalinowska-Łyszczarz
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 90-100
Open Access | Times Cited: 2
Exposure to systemic antibiotics in outpatient care and the risk of multiple sclerosis
Jussi Sipilä, Matias Viitala, Arno Hänninen, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 10, pp. 1296-1303
Open Access | Times Cited: 2
Validation of algorithms for identifying outpatient infections in MS patients using electronic medical records
Jessica B. Smith, Bonnie H. Li, Edlin Gonzales, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 57, pp. 103449-103449
Closed Access | Times Cited: 4
Comparing the risk of serious infections in patients with and without MS: A German claims data analysis
Rachel Knapp, F. Hardtstock, Thomas Wilke, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 72, pp. 104583-104583
Closed Access | Times Cited: 1
Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study
Jonas Graf, Huah Shin Ng, Feng Zhu, et al.
The Lancet Regional Health - Americas (2024) Vol. 29, pp. 100667-100667
Open Access
COVID-19 Vaccination Coverage and Associated Factors in Patients with Multiple Sclerosis
Ignacio Hernández-García, Joana Rodríguez-Montolio, M. Almeida-Zurita, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 126-126
Open Access
Performance Measures and Plasma Biomarker Levels in Patients with Multiple Sclerosis after 14 Days of Fampridine Treatment: An Explorative Study
Maria Thorning, Kate Lykke Lambertsen, Henrik Boye Jensen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1592-1592
Open Access
Unraveling the complex relationship: Multiple sclerosis, urinary tract infections, and infertility
Maryam Seyedolmohadesin, Maedeh Ashkani, Taravat Sadeghi Ghadikolaei, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 84, pp. 105512-105512
Closed Access
Comorbilidades en la esclerosis múltiple y su influencia en la elección del tratamiento
Andrés Barboza, Vladimiro Sinay, Ricardo Alonso, et al.
Revista de Neurología (2024) Vol. 78, Iss. 06, pp. 157-157
Open Access
Effects of vaccination on COVID-19 infection symptoms in multiple sclerosis patients
Parisa Sharifi, Nasim Rezaeimanesh, Amir Moradi, et al.
eNeurologicalSci (2024) Vol. 36, pp. 100511-100511
Open Access
A real-world pharmacovigilance study of Ocrelizumab based on FAERS database
Haiping Liang, Junlin Wu, Lili Chen, et al.
Research Square (Research Square) (2024)
Open Access
Features of the vaginal microbiota in women with relapsing-remitting multiple sclerosis
Е. И. Лузанова, М. И. Карпова, О. С. Абрамовских, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 17, pp. 58-65
Open Access
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis
Emanuela Zappulo, Antonio Riccardo Buonomo, Marcello Moccia, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103814-103814
Closed Access | Times Cited: 2
Is Monkeypox a Concern in Multiple Sclerosis Patients? A Letter to Editor.
Elnaz Asadollahzadeh, Fereshteh Ghadiri, Zahra Ebadi, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 10, Iss. 1, pp. e67-e67
Closed Access | Times Cited: 2
Infecciones del tracto urinario en pacientes con esclerosis múltiple y los diferentes sistemas de vaciado vesical
Gabriel Varga, M. Fedorko, R. Wasserbauer, et al.
Actas Urológicas Españolas (2022) Vol. 46, Iss. 10, pp. 606-612
Closed Access | Times Cited: 1
Urinary tract infections in patients with multiple sclerosis and different methods of bladder evacuation
Gabriel Varga, M. Fedorko, R. Wasserbauer, et al.
Actas Urológicas Españolas (English Edition) (2022) Vol. 46, Iss. 10, pp. 606-612
Closed Access | Times Cited: 1
Outcomes and Health Care Service Use in Adults 50 Years or Older With and Without Multiple Sclerosis: A 6-Year Observational Analysis
Léorah Freeman, Ashlea Lucas, Jia Zhou, et al.
International Journal of MS Care (2022) Vol. 25, Iss. 2, pp. 56-62
Open Access | Times Cited: 1
Non-HLA Genes and Multiple Sclerosis
Jamilah Borjac, Alaa Matar, Maxime Merheb, et al.
The Open Biotechnology Journal (2023) Vol. 17, Iss. 1
Open Access
Previous Page - Page 2

Scroll to top